Scholarly-open-access-drug-designing-journals|OMICS International|Drug Designing: Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Scholarly Open Access Drug Designing Journals

Drug Designing Open Access is a scholarly journal that is available online to the reader "without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. A few obvious advantages of Drug Designing Open Access include the free access to scientific papers regardless of affiliation with a subscribing library, lower costs for research in academia and industry, in addition to improved access for the general public and higher citation rates for the author. Drug Designing Open Access is a journal dedicated to producing analysis, insight and data relating to questions of importance of the drug designing. Drug Designing Open Access strives to release issues quarterly and is adamant to publish new findings related to the field of in-silico drug designing, high-throughput screening, drug targets, and structure-activity relationships.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on February, 2021